argenx SE
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell argenx SE and other ETFs, options, and stocks.About ARGX
argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China.
CEOTim van Hauwermeiren
CEOTim van Hauwermeiren
Employees1,599
Employees1,599
HeadquartersAmsterdam, Noord-Holland
HeadquartersAmsterdam, Noord-Holland
Founded2008
Founded2008
Employees1,599
Employees1,599
ARGX Key Statistics
Market cap42.75B
Market cap42.75B
Price-Earnings ratio32.37
Price-Earnings ratio32.37
Dividend yield—
Dividend yield—
Average volume350.78K
Average volume350.78K
High today$691.28
High today$691.28
Low today$683.24
Low today$683.24
Open price$685.74
Open price$685.74
Volume12.34K
Volume12.34K
52 Week high$934.62
52 Week high$934.62
52 Week low$510.06
52 Week low$510.06
ARGX News
TipRanks 4d
Argenx Halts Phase 3 Thyroid Eye Disease Trial: Clinical Setback With Focused Market ImpactArgenx (ARGX) announced an update on their ongoing clinical study. Argenx Ends Key Thyroid Eye Disease Trial: What Investors Need to Know The phase 3 study “A...
TipRanks 4d
Argenx Ends Phase 3 Thyroid Eye Disease Trial, Resetting Expectations for EfgartigimodArgenx (ARGX) announced an update on their ongoing clinical study. The phase 3 UplighTED trial (NCT06307626) tested Argenx’s efgartigimod PH20 SC, delivered by...
Analyst ratings
86%
of 29 ratingsBuy
86.2%
Hold
13.8%
Sell
0%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.